Logo do repositório
 
Miniatura indisponível
Publicação

The Bsmoc group as a novel scaffold for the design of irreversible inhibitors of cysteine proteases

Utilize este identificador para referenciar este registo.

Orientador(es)

Resumo(s)

Carbamate and ester derivatives of the 1,1-dioxobenzo[b]thiophen-2-ylmethyloxycarbonyl (Bsmoc) scaffold react readily with thiols via a Michael addition at rates not significantly affected by the nature of the carboxylic or carbamic acid leaving group. These Michael acceptors are irreversible inhibitors of the cysteine proteases papain and human liver cathepsin B, displaying first-order kinetics with respect to inhibitor concentration. In contrast, none of the Bsmoc derivatives inhibited porcine pancreatic elastase, a serine protease. (C) 2006 Elsevier Ltd. All rights reserved.

Descrição

Palavras-chave

Chemistry, Medicinal Chemistry, Organic

Contexto Educativo

Citação

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. - Vol. 16, n. 10 (MAY 15 2006), p. 2738-2741

Projetos de investigação

Unidades organizacionais

Fascículo

Editora

PERGAMON-ELSEVIER SCIENCE LTD

Licença CC

Métricas Alternativas